Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT02805712
This small pilot study will be assessing the the impact of a standardized, social-worker led, longitudinal palliative care intervention on alignment of patient and physician understanding of prognosis and goals of care. Secondary objectives include assessing the impact of this intervention on documentation of advanced care planning and end of life preferences, symptom burden, quality of life and health care utilization.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
Patients will be assigned to one of two groups a) longitudinal goals of care discussion led by a palliative care-trained social worker or b) usual care + written information regarding advanced directives. The intervention group will be enrolled in the hospital and then be followed longitudinally for 3 months by a palliative care-trained social worker who will shepherd a conversation around prognosis, expectations, and goals of care. The results of these conversations will be documented in the electronic medical record and shared with the clinical team. Clinical symptoms that are identified during these conversations will be evaluated by a Palliative Care Physician who will relay suggestions regarding management to the primary treating clinician. Baseline surveys will assess prognostic awareness, symptom burden, anxiety, depression, and quality of life for both groups. At the conclusion of the study, an individualized follow-up plan will be devised for each patient based on a needs assessment by the study social worker.
Patients assigned to the control/usual care arm will complete the same series of questionnaires as those assigned to the intervention group and will undergo usual in hospital and post-discharge treatment as directed by their care team. All control subjects will receive written Advanced Care planning and Heart Failure education materials as provided routinely to inpatients at Brigham and Women's Hospital. At the 6 month visit following hospitalization, these patients will be asked to complete follow up questionnaires and then will be given the option to participate in the above verbal intervention and guided "Goals and Values" conversation that was provided to the intervention group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intervention patient will receive a outpatient session with a palliative care social worker in the heart failure clinic two weeks post discharge consent focusing on goals of care.
The control group will receive usual written care material and a palliative care consult if ordered by physician.
Time frame: 6 months
Assessment tool: Patient Preferences Questionnaire.
Time frame: 6 months
Chart review of Advanced Care Planning documents and written notes by members of clinical team.
Time frame: Three months
Assessment tool: : The Kansas City Cardiomyopathy Questionnaire (KCCQ-12)
Time frame: 6 months
Assessment tool: EQ visual analogue scale (EQ-VAS)
Time frame: Three months
Assessment tool: The Functional Assessment of Chronic Illness Therapy ( FACIT-Sp)
Time frame: 6 months
Assessment tool: Patient Health Questionnaire (PHQ-8)
Time frame: 6 months
Assessment tool: General Anxiety Disorder (GAD-7)
Time frame: 6 months
Focus will be on cost through health care utilization as aggregated by number of hospital days, days in ICU and 30 day re-admissions.
Brigham and Women's Hospital
Other
Pilot Study of a Focused Palliative Care Intervention for Recently Hospitalized High-Risk Patients With Heart Failure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06791967
Behavior, Behavioral Symptoms
Taipei, Taiwan
View Trial DetailsNCT07041827
Cardiomyopathies, Cardiotoxicity
Amsterdam, North Holland, Netherlands
View Trial DetailsNCT04066153
Cancer, Cardiovascular Diseases
Copenhagen, Denmark
View Trial DetailsNCT06068309
Adherence, Medication, Asthma
George Town, Pulau Pinang, Malaysia
View Trial Details